MariMed Inc. (CSE:MRMD)

MariMed Statistics

Total Valuation

MariMed has a market cap or net worth of CAD 45.15 million. The enterprise value is 173.66 million.

Market Cap	45.15M
Enterprise Value	173.66M

Important Dates

The next estimated earnings date is Wednesday, March 4, 2026.

Earnings Date	Mar 4, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	395.25M
Shares Outstanding	n/a
Shares Change (YoY)	+2.31%
Shares Change (QoQ)	+0.70%
Owned by Insiders (%)	10.51%
Owned by Institutions (%)	0.25%
Float	330.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.21
PB Ratio	0.47
P/TBV Ratio	2.09
P/FCF Ratio	19.52
P/OCF Ratio	8.41
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.42, with an EV/FCF ratio of 75.06.

EV / Earnings	-7.00
EV / Sales	0.80
EV / EBITDA	8.42
EV / EBIT	115.77
EV / FCF	75.06

Financial Position

The company has a current ratio of 1.06, with a Debt / Equity ratio of 1.25.

Current Ratio	1.06
Quick Ratio	0.26
Debt / Equity	1.25
Debt / EBITDA	5.81
Debt / FCF	52.02
Interest Coverage	0.15

Financial Efficiency

Return on equity (ROE) is -22.81% and return on invested capital (ROIC) is 0.41%.

Return on Equity (ROE)	-22.81%
Return on Assets (ROA)	0.32%
Return on Invested Capital (ROIC)	0.41%
Return on Capital Employed (ROCE)	0.73%
Revenue Per Employee	283,221
Profits Per Employee	-32,063
Employee Count	832
Asset Turnover	0.75
Inventory Turnover	2.59

Taxes

In the past 12 months, MariMed has paid 15.64 million in taxes.

Income Tax	15.64M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.00% in the last 52 weeks. The beta is 1.00, so MariMed's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	-50.00%
50-Day Moving Average	0.18
200-Day Moving Average	0.17
Relative Strength Index (RSI)	34.45
Average Volume (20 Days)	30,157

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.04

Income Statement

In the last 12 months, MariMed had revenue of CAD 219.21 million and -24.82 million in losses. Loss per share was -0.07.

Revenue	219.21M
Gross Profit	83.98M
Operating Income	1.51M
Pretax Income	-9.12M
Net Income	-24.82M
EBITDA	17.76M
EBIT	1.51M
Loss Per Share	-0.07

Balance Sheet

The company has 9.19 million in cash and 120.34 million in debt, giving a net cash position of -111.16 million.

Cash & Cash Equivalents	9.19M
Total Debt	120.34M
Net Cash	-111.16M
Net Cash Per Share	n/a
Equity (Book Value)	96.17M
Book Value Per Share	0.20
Working Capital	4.89M

Cash Flow

In the last 12 months, operating cash flow was 5.37 million and capital expenditures -3.05 million, giving a free cash flow of 2.31 million.

Operating Cash Flow	5.37M
Capital Expenditures	-3.05M
Free Cash Flow	2.31M
FCF Per Share	n/a

Margins

Gross margin is 38.31%, with operating and profit margins of 0.69% and -11.32%.

Gross Margin	38.31%
Operating Margin	0.69%
Pretax Margin	-4.16%
Profit Margin	-11.32%
EBITDA Margin	8.10%
EBIT Margin	0.69%
FCF Margin	1.06%

Dividends & Yields

MariMed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.31%
Shareholder Yield	-2.31%
Earnings Yield	-54.97%
FCF Yield	5.12%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MariMed has an Altman Z-Score of 0.16 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.16
Piotroski F-Score	4